medigraphic.com
ISSN 1561-3070 (Electronic)

2016, Number 1

<< Back Next >>

Rev Cub Oftal 2016; 29 (1)

Late complications of the ocular radiotherapy

González GJL, Santos SD, Abreu PFA, Melgares RMÁ, Valdivia BYT

Language: Spanish
References: 19
Page: 141-147
PDF size: 308.81 Kb.


ABSTRACT

Radiotherapy is one of the therapeutic pillars used in oncology, but ocular damage may occur and this is a well-established phenomenon. The occurrence of complications remains the main concern for the application of radiotherapy, despite the use of new strategies to reduce complications and to improve the therapeutic rate. Here is a 63 years old female patient, who was diagnosed with epidermoid carcinoma of the conjunctiva, moderately differentiated G-II invader (T3N0M0) in the left eye. She was surgically treated and received supplementary superficial radiotherapy As a late complication, the patient presented with radiogenic cataract treated by surgery, in addition to conjunctival aneurysms in the treated area as well.


REFERENCES

  1. Finger TP. Radiation treatment. In: Karcioglu AZ. Orbital tumors diagnosis and treatment. New York: Springer; 2005. p. 398-409.

  2. Montero A, Hervás A, Morera R, Sancho S, Córdoba S, Corona JA, et al. Control de síntomas crónicos: efectos secundarios del tratamiento con radioterapia y quimioterapia. Oncología. 2005 [citado 17 de abril de 2014];28(3):41-50. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid= S037848352005000300008&lng=es

  3. Sanabria MR, Fernández-Muñoz M. Complicaciones oculares tras teleterapia: caso clínico. Arch Soc Esp Oftalmol. 2007 [citado 3 de abril de 2014];82(6):361-4. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid= S036566912007000600008&lng=es

  4. Yadav BS, Sharma SC. Orbital lymphoma: role of radiation. Indian J Ophthalmol. 2009 [citado 3 de abril de 2014];57(2):91-7. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684420/

  5. Whelan KF. Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study. Pediatr Blood Cancer. 2010 [citado 2 de abril de 2014];54(1):103-9. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783513/

  6. Cho WK, Lee SE, Paik JS, Cho SG, Yang SW. Risk potentiality of frontline radiotherapy associated cataract in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma. Korean J Ophthalmol. 2013 [citado 3 de abril de 2014];27(4):243-8. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730065/

  7. Tsimpida M, Hungerford J, Arora A, Cohen V. Plaque radiotherapy treatment with ruthenium-106 for iris malignant melanoma. Eye. 2011 [citado 3 de abril de 2014];25(12):1607-11. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234466/

  8. Choi SY. Long term follow-up results of external beam radiotherapy as primary treatment for retinoblastoma. J Korean Med Sci. 2010 [citado 2 de abril de 2014];25(4):546-51. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844604/

  9. Huh WW, Mahajan A. Multidisciplinary management of orbital rhabdomyosarcoma. In: Esmaeli B. Ophthalmic Oncology. London: Springer; 2011. p. 61-7.

  10. Groenewald C, Konstantinidis L, Damato B. Effects of radiotherapy on uveal melanomas and adjacent tissues. Eye. 2013 [citado 2 de abril de 2014];27(2):163- 71. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574249/

  11. Nam H, Ahn YC, Kim YD. Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma. Radiother Oncol. 2009;90:236-41.

  12. Behrens R, Dietze G. Monitoring the eye lens: which dose quantity is adequate? Phys Med Biol. 2010;55:4047-62.

  13. Ferreri AJ, Dolcetti R, Du MQ. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol. 2008;19:835-46.

  14. Stefanovic A, Lossos IS. Extranodal marginal zone lymphoma of the ocular adnexa. Blood. 2009;114:501-10.

  15. De Cicco L, Cella L, Liuzzi R. Radiation therapy in primary orbital lymphoma: a single institution retrospective analysis. Radiat Oncol. 2009;4:60.

  16. Son SH, Choi BO, Kim GW. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma). Int J Radiat Oncol Biol Phys. 2010;77:86-91.

  17. Damato B, Kacperek A, Errington D. Heimann: Proton beam radiotherapy of uveal melanoma. Saudi J Ophthalmol. 2013 [citado 3 de abril de 2014];27(3):151-7. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770228/

  18. Gupta A, Dhawahir-Scala F, Smith A, Young L, Charles S. Radiation retinopathy: case report and review. BMC Ophthalmol. 2007 [citado 3 de abril de 2014];7:6. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855313/

  19. Ghauri AJ, Musadiq M, Sha Y, Elsherbini S. Late onset of subfoveal choroidal neovascularization following cerebral radiotherapy. BMJ. 2010 [citado 3 de abril de 2014]. Disponioble en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3027866/




2020     |     www.medigraphic.com